Lilly To Include Dexcom's Technology Into Its Diabetes Management System
Summary
(RTTNews) - Eli Lilly and Company (LLY) has reached a global commercialization agreement to integrate DexCom, Inc. (DXCM) products into Lillys personalized diabetes management system. Under the agreement, Lilly will use Dexcoms continuous glucose monitoring devices in both the pen- and pump-based platforms of the system being designed to help improve diabetes management. Rick Doubleday, chief commercial officer of Dexcom, stated: "Were looking forward to expanding our collaboration with Lilly as we integrate our technology into their system and believe it will help reduce some of the complexity that can come from managing diabetes every day."
Classifications
industries
HealthTech
applications
Web and Content Management
AskAI Classifications
Labels
Healthcare Software
Digital Health
SaaS
Linked Companies
Dexcom, Inc.
$1M to $5M